![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 63, Issue 2, 368-377, February 2003
Jean Mayer United States Department of Agriculture Human Nutrition
Research Center on Aging (Y.K., A.-G.M., S.N.F., Y.J.S.) and Pulmonary
and Critical Care Division (A.R.S., Y.J.S.), Department of
Medicine, Tufts University, Boston, Massachusetts; Protein Science
Laboratory (K.K.), National Food Research Institute, Tsukuba, Japan;
Hokkaido Food Processing Research Center (T.I., Y.I.), Hokkaido, Japan;
and Department of Developmental and Molecular Biology (T.E.), Albert
Einstein College of Medicine, Bronx, New York
Anthracyclines are effective cancer chemotherapeutic agents but can
induce serious cardiotoxicity. Understanding the mechanism of cardiac
damage by these agents will help in development of better therapeutic
strategies against cancer. The GATA-4 transcription factor is an
important regulator of cardiac muscle cells. The present study
demonstrates that anthracyclines can down-regulate GATA-4 activity.
Treatment of HL-1 cardiac muscle cells or isolated adult rat
ventricular myocytes with anthracyclines such as daunorubicin and
doxorubicin decreased the level of GATA-4 DNA-binding activity. The
mechanism of decreased GATA-4 activity acts at the level of the GATA-4
gene, because anthracyclines caused significantly decreased levels of
GATA-4 protein and mRNA. The rate of decline in GATA-4 transcript
levels in the presence of actinomycin D was unaltered by
anthracyclines, indicating that these agents may affect directly GATA-4
gene transcription. To determine whether decreased GATA-4 levels are
functionally related to cardiac muscle cell death that can be induced
by anthracyclines, the ability of ectopic GATA factors to rescue
anthracycline-induced apoptosis was tested. Adenovirus-mediated
expression of either GATA-4 or GATA-6 was sufficient to attenuate the
incidence of apoptosis. Furthermore, suppression of GATA-4 DNA-binding
activity by a dominant negative mutant of GATA-4 induced the apoptosis.
These results suggest that the mechanism of anthracycline-induced
cardiotoxicity may involve the down-regulation of GATA-4 and the
induction of apoptosis.
This article has been cited by other articles:
|
|
 |
|
  K. Venkatachalam, S. D. Prabhu, V. S. Reddy, W. H. Boylston, A. J. Valente, and B. Chandrasekar Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury J. Biol. Chem., March 20, 2009; 284(12): 7853 - 7865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lee, D. Z. Qian, S. Rey, H. Wei, J. O. Liu, and G. L. Semenza Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells PNAS, February 17, 2009; 106(7): 2353 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Canzoneri and A. K. Oyelere Interaction of anthracyclines with iron responsive element mRNAs Nucleic Acids Res., December 1, 2008; 36(21): 6825 - 6834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rojas, S. W. Kong, P. Agarwal, B. Gilliss, W. T. Pu, and B. L. Black GATA4 Is a Direct Transcriptional Activator of Cyclin D2 and Cdk4 and Is Required for Cardiomyocyte Proliferation in Anterior Heart Field-Derived Myocardium Mol. Cell. Biol., September 1, 2008; 28(17): 5420 - 5431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Bjelogrlic, J. Radic, S. Radulovic, M. Jokanovic, and V. Jovic Effects of Dexrazoxane and Amifostine on Evolution of Doxorubicin Cardiomyopathy In Vivo Experimental Biology and Medicine, December 1, 2007; 232(11): 1414 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bien, A. Riad, C. A. Ritter, M. Gratz, F. Olshausen, D. Westermann, M. Grube, T. Krieg, S. Ciecholewski, S. B. Felix, et al. The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy Cancer Res., November 1, 2007; 67(21): 10428 - 10435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Suzuki, H. Nagase, C. M. Wong, S. V. Kumar, V. Jain, A.-M. Park, and R. M. Day Regulation of Bcl-xL Expression in Lung Vascular Smooth Muscle Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 678 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Park and Y. J. Suzuki Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice J Appl Physiol, May 1, 2007; 102(5): 1806 - 1814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Oka, M. Maillet, A. J. Watt, R. J. Schwartz, B. J. Aronow, S. A. Duncan, and J. D. Molkentin Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability Circ. Res., March 31, 2006; 98(6): 837 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bielinska, S. Kiiveri, H. Parviainen, S. Mannisto, M. Heikinheimo, and D. B. Wilson Gonadectomy-induced Adrenocortical Neoplasia in the Domestic Ferret (Mustela putorius furo) and Laboratory Mouse. Vet. Pathol., February 1, 2006; 43(2): 97 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, G. Takemura, Y. Li, S. Miyata, M. Esaki, H. Okada, H. Kanamori, N. C. Khai, R. Maruyama, A. Ogino, et al. Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy Circulation, January 31, 2006; 113(4): 535 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chagnon, C. N. Metz, R. Bucala, and O. Lesur Endotoxin-Induced Myocardial Dysfunction: Effects of Macrophage Migration Inhibitory Factor Neutralization Circ. Res., May 27, 2005; 96(10): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. Preston, G. Tang, J. U. Tilan, N. S. Hill, and Y. J. Suzuki Retinoids and Pulmonary Hypertension Circulation, February 15, 2005; 111(6): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chandrasekar, S. Mummidi, W. C. Claycomb, R. Mestril, and M. Nemer Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes J. Biol. Chem., February 11, 2005; 280(6): 4553 - 4567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pikkarainen, H. Tokola, R. Kerkela, and H. Ruskoaho GATA transcription factors in the developing and adult heart Cardiovasc Res, August 1, 2004; 63(2): 196 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L'Ecuyer, Z. Allebban, R. Thomas, and R. Vander Heide Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2057 - H2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aries, P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity PNAS, May 4, 2004; 101(18): 6975 - 6980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. White, P. E. Constantin, and W. C. Claycomb Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H823 - H829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. LaVoie The Role of GATA in Mammalian Reproduction Experimental Biology and Medicine, December 1, 2003; 228(11): 1282 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Suzuki, R. M. Day, C. C. Tan, T. H. Sandven, Q. Liang, J. D. Molkentin, and B. L. Fanburg Activation of GATA-4 by Serotonin in Pulmonary Artery Smooth Muscle Cells J. Biol. Chem., May 2, 2003; 278(19): 17525 - 17531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitta, R. M. Day, Y. Kim, I. Torregroza, T. Evans, and Y. J. Suzuki Hepatocyte Growth Factor Induces GATA-4 Phosphorylation and Cell Survival in Cardiac Muscle Cells J. Biol. Chem., February 7, 2003; 278(7): 4705 - 4712. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
